Oculis
Recent Finacing
Equity
Recent Raise
$110M
Oculis is a Swiss-Icelandic ophthalmology company developing innovative therapies for ocular and neurological diseases.
Highlights
Focus Areas
Biotechnology
Health Care
Pharmaceutical
Recent Investors
Financials
$296.2M
Total Raised
6
Funding rounds
13
Investors